In three subtypes (ER+ MCF7, HER2+ SK-BR-3, triple negative HCC1806 and MDA-MB-231 cells) of human breast cancer cell lines, ATRA alone was not able to modulate cell cycle regulators. Here, ERBB2 is linked to breast carcinoma.